ITGA11: A Transmembrane Protein with Potential as A Drug Target

Target Name: ITGA11

NCBI ID: G22801

ITGA11

ITGA11: A Transmembrane Protein with Potential as A Drug Target

ITGA11, also known as Integrin alpha-11, is a protein that is expressed in many different tissues in the body. It is a type of transmembrane protein that is composed of two extracellular domains and one intracellular domain. The intracellular domain of ITGA11 is responsible for interacting with various intracellular signaling pathways and is involved in the regulation of cell adhesion, migration, and survival.

ITGA11 has been identified as a potential drug target and has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

Structure and Function

ITGA11 is a transmembrane protein that consists of four domains: an extracellular domain, a transmembrane domain, an intracellular domain, and an N-terminus. The extracellular domain of ITGA11 consists of a single subdomain that is involved in the regulation of cell adhesion and migration. This subdomain is known as the N-terminal domain and is composed of a transmembrane protein that contains a unique fenestral domain that is involved in the regulation of cell adhesion and migration.

The transmembrane domain of ITGA11 is the largest and is responsible for the protein's ability to interact with various signaling pathways. This domain is known as the T-module and is composed of multiple transmembrane helices that are involved in the regulation of cell adhesion, migration, and survival. The intracellular domain of ITGA11 is the smallest and is responsible for the protein's ability to interact with various intracellular signaling pathways. This domain is known as the C-terminal domain and is composed of a single transmembrane protein that is involved in the regulation of cell adhesion, migration, and survival.

ITGA11 is involved in the regulation of cell adhesion and migration by interacting with various signaling pathways. One of the most well-known signaling pathways that ITGA11 is involved in is the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival and is composed of a complex network of proteins that are involved in the regulation of cell adhesion, migration, and survival. ITGA11 is a key regulator of the TGF-β pathway and is involved in the regulation of cell adhesion and migration.

ITGA11 is also involved in the regulation of cell signaling pathways that are responsible for the regulation of cell survival and growth. One of the most well-known signaling pathways that ITGA11 is involved in is the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell survival and growth and is composed of a complex network of proteins that are involved in the regulation of cell signaling pathways. ITGA11 is a key regulator of the PI3K/Akt signaling pathway and is involved in the regulation of cell survival and growth.

ITGA11 is also involved in the regulation of cell signaling pathways that are responsible for the regulation of cell differentiation and plasticity. One of the most well-known signaling pathways that ITGA11 is involved in is the T-cell receptor (TCR) signaling pathway. This pathway is involved in the regulation of cell differentiation and plasticity and is composed of a complex network of proteins that are involved in the regulation of cell signaling pathways. ITGA11 is a key regulator of the TCR signaling pathway and is involved in the regulation of cell differentiation and plasticity.

Drug Development

ITGA11 is a drug target that has the potential to be used for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Researchers have shown that ITGA11 is involved in the regulation of cell adhesion, migration, and survival and is a key regulator of the TGF-β, PI3K/Akt, and TCR signaling pathways. As a result, ITGA11 has

Protein Name: Integrin Subunit Alpha 11

Functions: Integrin alpha-11/beta-1 is a receptor for collagen

The "ITGA11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ITGA11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets